DR MAEVE DUFFY
Maeve Duffy has almost 20 years’ experience in the pharmaceutical industry working in a variety of roles ranging from Clinical Project Manager, Head/Director of Clinical Operations through to Head of Clinical Development. A strong scientific background underpins this broad work experience and includes a BSc in pharmacology, a PhD in biochemistry and a post-doctoral position in gastroenterology. An extensive experience in drug development includes pre-clinical development of NCEs through to clinical development of formulated investigational medicinal products (oral, IV, topical, transdermal) in a variety of therapeutic areas, most recently inflammation and CNS. Recent notable achievements include driving the company’s lead compound (VAP-1 Inhibitor) to a successful Phase 2 proof of concept, and subsequently out licensing the compound to a top five pharmaceutical company. Since this out-licensing deal, Maeve has led a cross-company project team and was a full member of the Joint Steering Committee. Maeve has also led the QA activities within the company. Maeve has previously held clinical positions within Serentis and Arakis and a large CRO, ICON Clinical Research.
Maeve is a graduate of the University College Dublin, where she studied pharmacology subsequently staying on at University College Dublin to complete a PhD in biochemistry.